covid
Buscar en
Endocrinología y Nutrición (English Edition)
Toda la web
Inicio Endocrinología y Nutrición (English Edition) What is happening with antiobesity drugs?
Journal Information
Vol. 58. Issue 3.
Pages 101-103 (March 2011)
Share
Share
Download PDF
More article options
Vol. 58. Issue 3.
Pages 101-103 (March 2011)
Full text access
What is happening with antiobesity drugs?
¿Qué está pasando con los fármacos para el tratamiento de la obesidad?
Visits
1258
Francisco José Tinahones
Servicio de Endocrinología y Nutrición, Hospital Clínico Virgen de la Victoria, Málaga, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, M. Zwahlen.
Bodymass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.
[2.]
K.D. Hopkins, D.E. Lehman.
Successful medical treatment of obesity in 10th century Spain.
Lancet, 346 (1995), pp. 452
[3.]
Division of Metabolic and Endocrine Drug Products, Food and Drug Administration. Guidance for the clinical evaluation of weight-control drugs, 1997.
[4.]
L. Abenhain, Y. Moride, F. Brenot, S. Rich, J. Benichou, X. Kurz, et al.
Appetite-suppressant drugs and the risk of primary pulmonary hypertension.
New Eng J Med, 335 (1996), pp. 609-616
[5.]
H.M. Conolly, J.L. Crary, M.D. McGoon, D.D. Hensrud, B.S. Edwards, W.D. Edwards, et al.
Valvular heart disease associated with fenfluramine-phentermine.
New Eng J Med, 337 (1997), pp. 581-588
[6.]
F.J. C-Soriguer, F.J. Tinahones.
Principio de precaución y tratamiento con fármacos de las personas obesas.
Med Clin (Barc), 112 (1999), pp. 503-507
[7.]
W.P. James, A. Astrup, N. Finer, J. Hilsted, P. Kopelman, S. Rössner, STORM Study Group, et al.
Sibutramine Trial of Obesity Reduction and Maintenance. Effect of sibutramine on weight maintenance after weight loss: a randomised trial.
Lancet, 356 (2000), pp. 2119-2125
[8.]
W.P.T. James.
The SCOUT study: risk benefit profile of sibutramine in overweight high-risk cardiovascular patients.
Eur Heart J Suppl, 7 (2005), pp. L44-L48
[9.]
L. Sjostrom, K. Narbro, C.D. Sjostrom, K. Karason, B. Larsson, H. Wedel, et al.
Effects of bariatric surgery on mortality in Swedish obese subjects.
N Engl J Med, 357 (2007), pp. 741-752
[10.]
A. Astrup, S. Rössner, L. Van Gaal, A. Rissanen, L. Niskanen, M. Al Hakim, et al.
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.
Lancet, 374 (2009), pp. 1606-1616
[11.]
P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, J.I. Gordon.
An obesity-associated gut microbiome with increased capacity for energy harvest.
Nature, 444 (2006), pp. 1027-1031
Copyright © 2011. Sociedad Española de Endocrinología y Nutrición
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos